(2,2-Dimethyl-2,3-dihydrobenzofuran-5-yl)boronic acid, 95%, 1g

tert-Butyl 4-bromo-2-hydroxybenzoate, 95.0%, 100mg

(2R,4R)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 10g

Tetrakis(4-ethynylphenyl)methane>97.0%(GC)1g

Bis(trimethylsilyl)carbodiimide, 98%, 5g

C -(1,3-Dimethyl-1 H -pyrazol-4-yl)-methylamine, 95.0%, 1g

(R)-3-Amino-1-(3-(cyclohexylmethoxy)phenyl)propan-1-ol hydrochloride, 98.0%, 1g

Tetrasodium Ethylenediaminetetraacetate Tetrahydrate, 99.0%, 25g

(R)-1-(TERT-BUTOXYCARBONYL)-4,4-DIFLUOROPYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 250mg

n-(3-Bromobenzyl)cyclopropanamine, 95%, 1g

Anti-GM1 Monoclonal Antibody1vial

(R)-2-((tert-Butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetic acid, 97%, 10g

Spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine], 95+%, 500mg